Ocular Therapeutix (OCUL) Other Non Operating Income (2013 - 2026)

Ocular Therapeutix has reported Other Non Operating Income for 13 years, with the latest figure at $689000.0 in Q2 2026.

• Other Non Operating Income for Q2 2026 came in at $689000.0, up 207.49% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.3 million (down 76.32% YoY), and the FY2025 annual result was -$2.5 million, up 91.16% from the prior year.
• Other Non Operating Income fell to $689000.0 in Q2 2026, from $1.5 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $14.2 million in Q3 2023 and troughed at -$28.0 million in Q1 2024.
• A 5-year average of -$101812.5 and a median of $642000.0 in 2025 frame the typical range for Other Non Operating Income.
• The widest annual swing landed in 2023, when Other Non Operating Income soared 1352.43%; it then plunged 367.64% in 2024.
• A 5-year view of Other Non Operating Income shows it stood at $5.2 million in 2022, then surged by 170.65% to $14.2 million in 2023, then slumped by 50.13% to $7.1 million in 2024, then sank by 91.59% to $595000.0 in 2025, then climbed by 15.8% to $689000.0 in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $689000.0 in Q2 2026, $1.5 million in Q1 2026, and $595000.0 in Q4 2025.